首页> Cancer Chemotherapy and Pharmacology> Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer

Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer

导出原文传递

翻译打印收藏纠错

第一作者： Hong,J.

作者： Hong,J. ^[1] ; Jung,M. ; Kim,Y.J. ; Sym,S.J. ; Kyung,S.Y. ; Park,J. ; Lee,S.P. ; Park,J.W. ; Cho,E.K. ; Jeong,S.H. ; Shin,D.B. ; Lee,J.H.

作者单位： Department of Internal Medicine, Gachon University Gil Hospital, Gachon University of Medicine, 21 ^[1]

关键词 Belotecan Chemotherapy Cisplatin Small cell lung carcinoma

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer Chemotherapy and Pharmacology

2012年69卷1期

215-220页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer Chemotherapy and Pharmacology

2012年69卷1期

215-220页

检索历史清除

Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer

Cancer Chemotherapy and Pharmacology

相似文献

同项目论文

Cancer Chemotherapy and Pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer

Cancer Chemotherapy and Pharmacology

相似文献

同项目论文

Cancer Chemotherapy and Pharmacology

相关期刊

检索历史清除